REPORT ID 3418

EMEA (Europe, Middle East and Africa) Sorafenib Market Report 2017

Publish Date
13-Dec-17
Pages
110
Format
Electronic (PDF)

In this report, the EMEA Sorafenib market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Sorafenib for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Sorafenib market competition by top manufacturers/players, with Sorafenib sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Allergan
    Alnylam Pharmaceuticals
    Acceleron Pharma
    Biocon
    Bionomics
    CASI Pharmaceuticals
    Celgene Corporation
    Enzon Pharmaceuticals
    Five Prime Therapeutics
    Fujifilm Kyowa Kirin Biologics
    Genentech
    Genexine
    Hetero Drugs
    ImClone Systems
    Intas Pharmaceuticals
    Levolta Pharmaceuticals
    Mabtech

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Capsule
    Tablet

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Sorafenib Market Report 2017
1 Sorafenib Overview
    1.1 Product Overview and Scope of Sorafenib
    1.2 Classification of Sorafenib
        1.2.1 EMEA Sorafenib Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Sorafenib Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Capsule
        1.2.4 Tablet
    1.3 EMEA Sorafenib Market by Application/End Users
        1.3.1 EMEA Sorafenib Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 EMEA Sorafenib Market by Region
        1.4.1 EMEA Sorafenib Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Sorafenib (2012-2022)
        1.5.1 EMEA Sorafenib Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Sorafenib Revenue and Growth Rate (2012-2022)

2 EMEA Sorafenib Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Sorafenib Market Competition by Players/Manufacturers
        2.1.1 EMEA Sorafenib Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Sorafenib Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Sorafenib Sale Price by Players (2012-2017)
    2.2 EMEA Sorafenib (Volume and Value) by Type/Product Category
        2.2.1 EMEA Sorafenib Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Sorafenib Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Sorafenib Sale Price by Type (2012-2017)
    2.3 EMEA Sorafenib (Volume) by Application
    2.4 EMEA Sorafenib (Volume and Value) by Region
        2.4.1 EMEA Sorafenib Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Sorafenib Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Sorafenib Sales Price by Region (2012-2017)

3 Europe Sorafenib (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Sorafenib Sales and Value (2012-2017)
        3.1.1 Europe Sorafenib Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Sorafenib Revenue and Growth Rate (2012-2017)
    3.2 Europe Sorafenib Sales and Market Share by Type
    3.3 Europe Sorafenib Sales and Market Share by Application
    3.4 Europe Sorafenib Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Sorafenib Sales Volume by Countries (2012-2017)
        3.4.2 Europe Sorafenib Revenue by Countries (2012-2017)
        3.4.3 Germany Sorafenib Sales and Growth Rate (2012-2017)
        3.4.4 France Sorafenib Sales and Growth Rate (2012-2017)
        3.4.5 UK Sorafenib Sales and Growth Rate (2012-2017)
        3.4.6 Russia Sorafenib Sales and Growth Rate (2012-2017)
        3.4.7 Italy Sorafenib Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Sorafenib Sales and Growth Rate (2012-2017)

4 Middle East Sorafenib (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Sorafenib Sales and Value (2012-2017)
        4.1.1 Middle East Sorafenib Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Sorafenib Revenue and Growth Rate (2012-2017)
    4.2 Middle East Sorafenib Sales and Market Share by Type
    4.3 Middle East Sorafenib Sales and Market Share by Application
    4.4 Middle East Sorafenib Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Sorafenib Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Sorafenib Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Sorafenib Sales and Growth Rate (2012-2017)
        4.4.4 Israel Sorafenib Sales and Growth Rate (2012-2017)
        4.4.5 UAE Sorafenib Sales and Growth Rate (2012-2017)
        4.4.6 Iran Sorafenib Sales and Growth Rate (2012-2017)

5 Africa Sorafenib (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Sorafenib Sales and Value (2012-2017)
        5.1.1 Africa Sorafenib Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Sorafenib Revenue and Growth Rate (2012-2017)
    5.2 Africa Sorafenib Sales and Market Share by Type
    5.3 Africa Sorafenib Sales and Market Share by Application
    5.4 Africa Sorafenib Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Sorafenib Sales Volume by Countries (2012-2017)
        5.4.2 Africa Sorafenib Revenue by Countries (2012-2017)
        5.4.3 South Africa Sorafenib Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Sorafenib Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Sorafenib Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Sorafenib Sales and Growth Rate (2012-2017)

6 EMEA Sorafenib Manufacturers/Players Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Sorafenib Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Allergan
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Sorafenib Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Allergan Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Alnylam Pharmaceuticals
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Sorafenib Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Alnylam Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Acceleron Pharma
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Sorafenib Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Acceleron Pharma Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Biocon
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Sorafenib Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Biocon Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Bionomics
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Sorafenib Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Bionomics Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 CASI Pharmaceuticals
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Sorafenib Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 CASI Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Celgene Corporation
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Sorafenib Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Celgene Corporation Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Enzon Pharmaceuticals
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Sorafenib Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Enzon Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Five Prime Therapeutics
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Sorafenib Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Five Prime Therapeutics Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Fujifilm Kyowa Kirin Biologics
    6.12 Genentech
    6.13 Genexine
    6.14 Hetero Drugs
    6.15 ImClone Systems
    6.16 Intas Pharmaceuticals
    6.17 Levolta Pharmaceuticals
    6.18 Mabtech

7 Sorafenib Manufacturing Cost Analysis
    7.1 Sorafenib Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Sorafenib

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Sorafenib Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Sorafenib Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Sorafenib Market Forecast (2017-2022)
    11.1 EMEA Sorafenib Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Sorafenib Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Sorafenib Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Sorafenib Price and Trend Forecast (2017-2022)
    11.2 EMEA Sorafenib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Sorafenib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Sorafenib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Sorafenib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Sorafenib Sales Forecast by Type (2017-2022)
    11.7 EMEA Sorafenib Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer